Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04666688
PHASE1/PHASE2

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Sponsor: PureTech

View on ClinicalTrials.gov

Summary

A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemotherapy or tislelizumab in Patients with Metastatic Solid Tumors

Official title: A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 as a Single Agent and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2020-12-11

Completion Date

2024-12-12

Last Updated

2026-11-16

Healthy Volunteers

No

Interventions

DRUG

LYT-200

monoclonal antibody (mAb), targeting galectin-9 protein

DRUG

Tislelizumab

anti-PD-1 monoclonal antibody

Locations (13)

UCLA

Los Angeles, California, United States

University of Colorado Hospital

Denver, Colorado, United States

Sarah Cannon Research Institute at Health One

Denver, Colorado, United States

Sarah Cannon Research Institute, Florida Cancer Specialists

Sarasota, Florida, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

South Texas Accelerated Research Therapeutics

Grand Rapids, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Columbia University

New York, New York, United States

Memorial Sloan-Kettering Cancer Center

New York, New York, United States

Sarah Cannon Research Institute, Tennessee Oncology

Nashville, Tennessee, United States

University of Texas, M.D. Anderson Cancer Center

Houston, Texas, United States

South Texas Accelerated Research Therapeutics

San Antonio, Texas, United States